Jasond Hanson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

enGene Appoints Lee Giguere as Chief Legal Officer and Corporate Secretary

enGene Appoints Lee Giguere as Chief Legal Officer and Corporate Secretary
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Northeastern universityUnited statesDerivatized oligochitosanJasond hansonBoston scientific corporationGene holdings incForbion european acquisition corporationExchange commissionBusiness administrationCompany annual report on formGoodwin procterNortheastern university school of lawGene holdingsChief legal officerChief executive officerObsidian therapeutics

EnGene Appoints Lota S Zoth, CPA, as Member of the Board of Directors

BOSTON and MONTREAL, Dec. 19, 2023 /PRNewswire/ - enGene Holdings Inc. , a clinical-stage genetic medicines company whose lead program is in a pivotal study for BCG-unresponsive non-muscle invasive.

United statesLumos pharmaDerivatized oligochitosanLotas zothJasond hansonGene holdings incCircassia pharmaceuticalsForbion european acquisition corporationCompany current report on formOrexigen therapeuticsMedimmune incAudit committeePsinet incErnst youngInovio pharmaceuticalsAudit committee chair

Engene (ENGN) Appoints Lota S Zoth to its Board

Engene (ENGN) Appoints Lota S Zoth to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Lotas zothLumos pharmaJasond hansonMedimmune incAudit committeeOrexigen therapeuticsInovio pharmaceuticalsGene holdings incPsinet incAudit committee chairErnst youngCircassia pharmaceuticalsGene holdingsChief executive officerSenior vice presidentChief financial officer

enGene Appoints Lota S Zoth, CPA, as Member of the Board of Directors

/PRNewswire/ - enGene Holdings Inc. ("enGene," Nasdaq: ENGN), a clinical-stage genetic medicines company whose lead program is in a pivotal study for.

United statesDerivatized oligochitosanLumos pharmaJasond hansonLotas zothMedimmune incExchange commissionInovio pharmaceuticalsAudit committee chairErnst youngAudit committeePsinet incForbion european acquisition corporationCircassia pharmaceuticalsGene holdings incOrexigen therapeutics

EnGene Appoints Ryan Daws as Chief Financial Officer

BOSTON and MONTREAL, Nov. 29, 2023 /PRNewswire/ - enGene Holdings Inc. , a clinical-stage genetic medicines company whose lead program is in a pivotal study for BCG-unresponsive non-muscle.

United statesDerivatized oligochitosanJasond hansonUniversity of south carolinaGene holdings incInternational master of business administrationForbion european acquisition corporationBusiness administrationPrior to concert pharmaceuticalsExchange commissionHead of business developmentNicolaus co incGene holdingsRyan dawsChief financial officerChief executive officer